US FDA probes tumour risk tied to Novartis gene therapy
Résumé détaillé
ZURICH: The US Food and Drug Administration said on Friday it was investigating a risk of neoplasia, or tumour formation including malignancy, associated wit ...
The Swiss drugmaker Novartis earlier in the day disclosed two cases in which tumours in children showed evidence of being linked to its gene therapy drug
Novartis said that it had received nine reports overall of tumours in patients previously treated with Zolgensma since the therapy was first approved in 2019. The logo of Swiss drugmaker Novartis for illustrative purposes. (Reuters)
Début de l'article, extrait de Emirates 24/7. Pour lire la suite, ouvrez l'article chez le média.
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.emirates247.com)
